(Q80211158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

gastrointestinal stromal tumor

29 December 2019

main subject

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tomoki Koyama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hiroshi Nimura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Katsutoshi Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hideki Marushima

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hironori Odaira

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Hirotaka Kashimura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Norio Mitsumori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

235-239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16952044%20AND%20SRC:MED&resulttype=core&format=json

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

29 December 2019

cites work

1 reference

12 December 2020

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

1 reference

12 December 2020

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

1 reference

12 December 2020

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.

1 reference

12 December 2020

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

1 reference

12 December 2020

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

1 reference

12 December 2020

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

1 reference

12 December 2020

Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.

1 reference

12 December 2020

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

12 December 2020

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

1 reference

12 December 2020

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

12 December 2020

A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient

1 reference

12 December 2020